Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of Daphmalenine A ramification to preparing rhinitis-resisting medicine

A technology for derivatives and rhinitis, applied in the field of preparation, Daphmalenine A derivatives, can solve the problems of poor curative effect and ineffectiveness of rhinitis, and achieve good anti-rhinitis effect

Inactive Publication Date: 2015-09-09
NANJING GUANGKANGXIE BIOLOGICAL MEDICAL TECH
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, antihistamine drugs such as terfenadine or antiallergic drugs such as tranilast and ketotifen are mainly used in the treatment of rhinitis. These drugs have poor or ineffective effects on chronicity and recurrent rhinitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Daphmalenine A ramification to preparing rhinitis-resisting medicine
  • Application of Daphmalenine A ramification to preparing rhinitis-resisting medicine
  • Application of Daphmalenine A ramification to preparing rhinitis-resisting medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] The preparation of embodiment 1 compound Daphmalenine A

[0020] The preparation method of compound Daphmalenine A (I) refers to the literature published by Yu Zhang et al. , 4103–4107) approach.

[0021]

Embodiment 2

[0022] The synthesis of the O-bromoethyl derivative (II) of embodiment 2 Daphmalenine A

[0023] Compound I (419 mg, 1.00 mmol) was dissolved in 10 mL of benzene, tetrabutylammonium bromide (TBAB) (0.08 g), 1,2-dibromoethane (7.520 g, 40.00 mmol) and 6 mL of 50% sodium hydroxide solution. The mixture was stirred at 35 °C for 12 h. After 12 hours, the reaction solution was poured into ice water, extracted twice with dichloromethane immediately, and the organic phase solutions were combined. Then the organic phase solution was washed with water and saturated brine four times successively, then dried with anhydrous sodium sulfate, and finally concentrated under reduced pressure to remove the solvent to obtain a crude product. The crude product was purified by silica gel column chromatography (mobile phase: petroleum ether / acetone=100:1.5, v / v), and the yellow concentrated elution band was collected to obtain compound II as a yellow solid (320 mg, 61%).

[0024] 1H NMR (500MHz,...

Embodiment 3

[0028] The synthesis of the O-(tetrahydropyrrolyl) ethyl derivative (III) of embodiment 3 Daphmalenine A

[0029] Compound II (263 mg, 0.5 mmol) was dissolved in 20 mL of acetonitrile, anhydrous potassium carbonate (345 mg, 2.5 mmol), potassium iodide (84 mg, 0.5 mmol) and pyrrolidine (2840 mg, 40 mmol) were added thereto, and the mixture was heated to reflux for 12 h. After the reaction, the reaction solution was poured into ice water, extracted four times with an equal amount of dichloromethane, and the organic phases were combined. The combined organic phases were successively washed with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to remove the solvent to obtain a crude product. The crude product was purified by silica gel column chromatography (mobile phase: petroleum ether / acetone=100:1.5, v / v), and the brown concentrated elution band was collected to obtain the O-(tetrahydropyrrolyl)ethyl derivative of Daphmale...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of organic synthesis and medicinal chemistry, and in particular to a Daphmalenine A ramification, a preparing method and application of the Daphmalenine A ramification to preparing a preparing rhinitis-resisting medicine. The new Daphmalenine A ramification is synthesized, and the preparing method of the new Daphmalenine A ramification is disclosed. Pharmacological tests show that the Daphmalenine A ramification has the rhinitis-resisting effect, and the Daphmalenine A ramification has the value for developing the rhinitis-resisting medicine.

Description

technical field [0001] The invention relates to the fields of organic synthesis and medicinal chemistry, in particular to a Daphmalenine A derivative, a preparation method and an application thereof. Background technique [0002] Rhinitis is a common and frequently-occurring disease in clinical practice. The occurrence of rhinitis is mainly related to allergic reactions and belongs to the category of immune inflammation. At present, antihistamine drugs such as terfenadine or antiallergic drugs such as tranilast and ketotifen are mainly used for the treatment of rhinitis, and these drugs have poor or ineffective effects on chronicity and recurrent rhinitis. Therefore, small molecular compounds with clear components, quality control, safety and high efficiency have potential value in the development of drugs for rhinitis treatment. [0003] It is most important to find compounds or lead compounds from natural products and obtain their derivatives through structural modificati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4355A61P11/02C07D491/107
Inventor 罗东君江春平吴俊华
Owner NANJING GUANGKANGXIE BIOLOGICAL MEDICAL TECH